Hmet-G 2mg/500mg Tablet is a combination oral antidiabetic medication containing Glimepiride 2mg and Metformin 500mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class agent, functions by stimulating pancreatic beta cells to increase insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, primarily decreases hepatic glucose production and improves peripheral insulin sensitivity, enhancing glucose uptake by muscle tissues. The synergistic action of these agents provides effective glycemic control in patients inadequately managed by diet and exercise alone. Hmet-G is typically prescribed when monotherapy with either agent is insufficient or when combination therapy is deemed appropriate. It is essential to initiate treatment with caution, considering patient-specific factors such as renal function, hepatic status, and risk of hypoglycemia. Common adverse effects may include gastrointestinal disturbances, hypoglycemia, and rarely, lactic acidosis associated with Metformin. Regular monitoring of blood glucose levels, renal function, and periodic assessment of hematologic parameters is recommended during therapy. Hmet-G should be used as part of a comprehensive diabetes management plan, including lifestyle modification and dietary control, to achieve optimal therapeutic outcomes.

Dosage & How to Use